| Mar 5, 2026 |
Mar 6, 2026 |
Fitzpatrick Jennifer
|
Chief Legal Officer |
Sell |
10.0
|
-10,250
|
-100.00%
|
✓
|
$347K |
| Feb 2, 2026 |
Feb 4, 2026 |
Thompson Peter A.
|
Director |
Sell |
27.5
|
-30,953
|
-0.87%
|
✗
|
$1.4M |
| Feb 2, 2026 |
Feb 4, 2026 |
ORBIMED ADVISORS LLC
|
Director |
Sell |
27.5
|
-30,953
|
-0.87%
|
✗
|
$1.4M |
| Jan 22, 2026 |
Jan 26, 2026 |
TPG GP A, LLC
|
10% Owner |
Sell |
15.0
|
-250,000
|
-3.71%
|
✗
|
$10M |
| Jan 2, 2026 |
Jan 6, 2026 |
McKee Charlotte
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 2, 2026 |
Jan 6, 2026 |
Fitzpatrick Jennifer
|
Chief Legal Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 2, 2026 |
Jan 6, 2026 |
Cloonan Michael
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 2, 2026 |
Jan 6, 2026 |
Beer Caroline Stark
|
Chief Business Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 2, 2026 |
Jan 6, 2026 |
Ridloff Elena
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 24, 2025 |
Dec 29, 2025 |
ORBIMED ADVISORS LLC
|
Director |
Sell |
27.5
|
-33,356
|
-0.93%
|
✗
|
$1.5M |
| Dec 24, 2025 |
Dec 29, 2025 |
Thompson Peter A.
|
Director |
Sell |
27.5
|
-33,356
|
-0.93%
|
✗
|
$1.5M |
| Dec 17, 2025 |
Dec 19, 2025 |
ORBIMED ADVISORS LLC
|
Director |
Sell |
47.5
|
-1,875
|
-0.05%
|
✗
|
$83.4K |
| Dec 17, 2025 |
Dec 19, 2025 |
Thompson Peter A.
|
Director |
Sell |
47.5
|
-1,875
|
-0.05%
|
✗
|
$83.4K |
| Dec 5, 2025 |
Dec 9, 2025 |
Fitzpatrick Jennifer
|
Chief Legal Officer |
Sell |
7.5
|
-10,250
|
-100.00%
|
✓
|
$415.3K |
| Nov 24, 2025 |
Nov 26, 2025 |
ORBIMED ADVISORS LLC
|
Director |
Sell |
17.5
|
-108,073
|
-2.92%
|
✗
|
$4.8M |
| Nov 24, 2025 |
Nov 26, 2025 |
Thompson Peter A.
|
Director |
Sell |
17.5
|
-108,073
|
-2.92%
|
✗
|
$4.8M |
| Nov 20, 2025 |
Nov 24, 2025 |
RA CAPITAL MANAGEMENT, L.P.
|
Director |
Sell |
42.5
|
-30,316
|
-0.10%
|
✗
|
$1.2M |
| Nov 17, 2025 |
Nov 19, 2025 |
RA CAPITAL MANAGEMENT, L.P.
|
Director |
Sell |
33.8
|
-136,351
|
-0.23%
|
✗
|
$5.5M |
| Oct 24, 2025 |
Oct 28, 2025 |
RA CAPITAL MANAGEMENT, L.P.
|
Director |
Sell |
15.0
|
-373,610
|
-1.82%
|
✗
|
$14.8M |
| Oct 21, 2025 |
Oct 22, 2025 |
Cloonan Michael
|
CEO |
Sell |
32.5
|
-99,800
|
-4.36%
|
✓
|
$3.6M |
| Oct 21, 2025 |
Oct 21, 2025 |
Booth Bruce
|
Director |
Sell |
36.3
|
-88,878
|
-2.88%
|
✓
|
$3M |
| Oct 16, 2025 |
Oct 20, 2025 |
Booth Bruce
|
Director |
Sell |
22.5
|
-286,369
|
-8.50%
|
✓
|
$9.3M |
| Oct 15, 2025 |
Oct 17, 2025 |
Cloonan Michael
|
CEO |
Sell |
42.5
|
-25,200
|
-1.51%
|
✓
|
$788.2K |
| Oct 10, 2025 |
Oct 15, 2025 |
Booth Bruce
|
Director |
Sell |
26.3
|
-194,932
|
-5.47%
|
✓
|
$5.9M |
| Oct 3, 2025 |
Oct 7, 2025 |
Booth Bruce
|
Director |
Sell |
40.0
|
-49,546
|
-1.37%
|
✓
|
$1.5M |
| Oct 1, 2025 |
Oct 3, 2025 |
Beer Caroline Stark
|
Chief Business Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Oct 3, 2025 |
Beer Caroline Stark
|
Chief Business Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 29, 2025 |
Oct 1, 2025 |
Booth Bruce
|
Director |
Sell |
36.3
|
-78,693
|
-2.13%
|
✓
|
$2.4M |
| Sep 26, 2025 |
Sep 30, 2025 |
Cloonan Michael
|
CEO |
Sell |
38.8
|
-25,000
|
-2.23%
|
✓
|
$727.8K |
| Sep 4, 2025 |
Sep 5, 2025 |
Fitzpatrick Jennifer
|
Chief Legal Officer |
Sell |
10.0
|
-10,250
|
-100.00%
|
✓
|
$237K |
| Aug 29, 2025 |
Sep 3, 2025 |
Ridloff Elena
|
CFO |
Sell |
20.0
|
-9,584
|
-19.92%
|
✓
|
$240.4K |
| Aug 26, 2025 |
Aug 28, 2025 |
Cloonan Michael
|
CEO |
Sell |
38.8
|
-25,000
|
-2.23%
|
✓
|
$624.4K |
| Aug 26, 2025 |
Aug 28, 2025 |
Ridloff Elena
|
CFO |
Sell |
7.5
|
-23,416
|
-32.74%
|
✓
|
$601.9K |
| Aug 20, 2025 |
Aug 21, 2025 |
Cloonan Michael
|
CEO |
Sell |
35.0
|
-25,000
|
-4.37%
|
✓
|
$568.8K |
| Aug 19, 2025 |
Aug 21, 2025 |
Ridloff Elena
|
CFO |
Sell |
5.0
|
-52,000
|
-42.09%
|
✓
|
$1.1M |
| Jun 27, 2025 |
Jul 1, 2025 |
TPG GP A, LLC
|
10% Owner |
Buy |
75.0
|
+60,000
|
0.90%
|
✗
|
$950.4K |
| Jun 12, 2025 |
Jun 16, 2025 |
RA CAPITAL MANAGEMENT, L.P.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 12, 2025 |
Jun 16, 2025 |
Viney Joanne L.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 12, 2025 |
Jun 16, 2025 |
Thompson Peter A.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 12, 2025 |
Jun 16, 2025 |
Stelzer Laurie
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 12, 2025 |
Jun 16, 2025 |
Ruddy Marcella K.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 12, 2025 |
Jun 16, 2025 |
Resnick Joshua
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 12, 2025 |
Jun 16, 2025 |
Fleming Harold Edward
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 12, 2025 |
Jun 16, 2025 |
Clancy Paul J
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 12, 2025 |
Jun 16, 2025 |
Booth Bruce
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Apr 1, 2025 |
Fitzpatrick Jennifer
|
Chief Legal Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 10, 2025 |
Feb 12, 2025 |
TPG GP A, LLC
|
10% Owner |
Buy |
100.0
|
+1,125,000
|
20.23%
|
✗
|
$20.3M |
| Feb 10, 2025 |
Feb 10, 2025 |
RA CAPITAL MANAGEMENT, L.P.
|
Director |
Buy |
100.0
|
+1,125,000
|
13.85%
|
✗
|
$20.3M |
| Feb 10, 2025 |
Feb 10, 2025 |
ORBIMED ADVISORS LLC
|
Director |
Buy |
100.0
|
+550,000
|
17.43%
|
✗
|
$9.9M |
| Feb 6, 2025 |
Feb 10, 2025 |
Ruddy Marcella K.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 6, 2025 |
Feb 10, 2025 |
Viney Joanne L.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 6, 2025 |
Feb 10, 2025 |
Cloonan Michael
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 6, 2025 |
Feb 10, 2025 |
Ridloff Elena
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 10, 2025 |
Feb 10, 2025 |
Thompson Peter A.
|
Director |
Buy |
100.0
|
+550,000
|
17.43%
|
✗
|
$9.9M |
| Feb 10, 2025 |
Feb 10, 2025 |
Booth Bruce
|
Director |
Buy |
95.0
|
+60,000
|
8.02%
|
✗
|
$1.1M |
| Feb 10, 2025 |
Feb 10, 2025 |
Atlas Venture Fund XI, L.P.
|
10% Owner |
Buy |
95.0
|
+60,000
|
8.02%
|
✗
|
$1.1M |
| Feb 6, 2025 |
Feb 10, 2025 |
McKee Charlotte
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Feb 6, 2025 |
TPG GP A, LLC
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Feb 6, 2025 |
Stelzer Laurie
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Feb 6, 2025 |
ORBIMED ADVISORS LLC
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Feb 6, 2025 |
McKee Charlotte
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Feb 6, 2025 |
Iancovici Lucian
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Feb 6, 2025 |
Ruddy Marcella K.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Feb 6, 2025 |
Atlas Venture Fund XI, L.P.
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Feb 6, 2025 |
Cloonan Michael
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Feb 6, 2025 |
RA CAPITAL MANAGEMENT, L.P.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Feb 6, 2025 |
Thompson Peter A.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Feb 6, 2025 |
Viney Joanne L.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Feb 6, 2025 |
Resnick Joshua
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Feb 6, 2025 |
Fleming Harold Edward
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Feb 6, 2025 |
Clancy Paul J
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Feb 6, 2025 |
Ridloff Elena
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Feb 6, 2025 |
Booth Bruce
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |